JPWO2023022973A5 - - Google Patents
Info
- Publication number
- JPWO2023022973A5 JPWO2023022973A5 JP2024509092A JP2024509092A JPWO2023022973A5 JP WO2023022973 A5 JPWO2023022973 A5 JP WO2023022973A5 JP 2024509092 A JP2024509092 A JP 2024509092A JP 2024509092 A JP2024509092 A JP 2024509092A JP WO2023022973 A5 JPWO2023022973 A5 JP WO2023022973A5
- Authority
- JP
- Japan
- Prior art keywords
- poly
- nucleic acid
- acid sequence
- antigen
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163233570P | 2021-08-16 | 2021-08-16 | |
| US63/233,570 | 2021-08-16 | ||
| US202163286952P | 2021-12-07 | 2021-12-07 | |
| US63/286,952 | 2021-12-07 | ||
| PCT/US2022/040317 WO2023022973A2 (en) | 2021-08-16 | 2022-08-15 | Compositions containing polynucleotide amphiphiles and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024534786A JP2024534786A (ja) | 2024-09-26 |
| JPWO2023022973A5 true JPWO2023022973A5 (https=) | 2025-08-13 |
| JP2024534786A5 JP2024534786A5 (https=) | 2025-08-13 |
Family
ID=85240944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509092A Pending JP2024534786A (ja) | 2021-08-16 | 2022-08-15 | ポリヌクレオチド両親媒性物質を含有する組成物及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250134992A1 (https=) |
| EP (1) | EP4388102A4 (https=) |
| JP (1) | JP2024534786A (https=) |
| AU (1) | AU2022329730A1 (https=) |
| CA (1) | CA3228856A1 (https=) |
| WO (1) | WO2023022973A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024226775A2 (en) * | 2023-04-26 | 2024-10-31 | Elicio Therapeutics, Inc. | Compositions containing polynucleotide and polypeptide amphiphiles and methods of use thereof |
| KR20260028688A (ko) * | 2023-05-25 | 2026-03-04 | 엘리시오 테라퓨틱스, 인크. | P53 펩티드 양친매체를 함유하는 조성물 및 이의 이용 방법 |
| KR20260027932A (ko) * | 2023-05-25 | 2026-03-03 | 엘리시오 테라퓨틱스, 인크. | Braf 펩티드 양친매체를 함유하는 조성물 및 이의 이용 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1629104A4 (en) * | 2003-06-04 | 2006-11-02 | Bioleaders Corp | CELL SURFACE EXPRESSION VECTOR OF SARS VIRUS ANTIGEN AND TRANSFORMED MICROORGANISMS |
| JP5759678B2 (ja) * | 2010-04-14 | 2015-08-05 | 国立大学法人埼玉大学 | 核酸リンカー |
| US9200314B2 (en) * | 2010-07-21 | 2015-12-01 | Takara Bio Inc. | Synthetic siRNA detection method |
| CN112587671A (zh) * | 2012-07-18 | 2021-04-02 | 博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
| WO2014039961A1 (en) * | 2012-09-07 | 2014-03-13 | University Of Miami | Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof |
| CN114762695A (zh) * | 2013-09-20 | 2022-07-19 | 国立研究开发法人医药基盘·健康·营养研究所 | 具有免疫增强活性的包含寡核苷酸的复合体及其用途 |
| US11219634B2 (en) * | 2015-01-21 | 2022-01-11 | Genevant Sciences Gmbh | Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells |
| DK3758712T3 (da) * | 2018-03-02 | 2025-08-04 | Elicio Therapeutics Inc | Cpg-amfifiler og anvendelser deraf |
| EP3941511A2 (en) * | 2019-03-20 | 2022-01-26 | Massachusetts Institute of Technology | Uses of amphiphiles in immune cell therapy and compositions therefor |
-
2022
- 2022-08-15 US US18/684,014 patent/US20250134992A1/en active Pending
- 2022-08-15 EP EP22858990.9A patent/EP4388102A4/en active Pending
- 2022-08-15 AU AU2022329730A patent/AU2022329730A1/en active Pending
- 2022-08-15 JP JP2024509092A patent/JP2024534786A/ja active Pending
- 2022-08-15 CA CA3228856A patent/CA3228856A1/en active Pending
- 2022-08-15 WO PCT/US2022/040317 patent/WO2023022973A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11920132B2 (en) | Oligonucleotide therapy for Leber congenital amaurosis | |
| TWI840321B (zh) | 用於B型肝炎病毒感染之RNAi藥劑 | |
| US7709449B2 (en) | Nucleic acid-based compounds and methods of use thereof | |
| CN101287742B (zh) | 基于变异应答调制Toll样受体的免疫调节寡核苷酸(IRO)化合物 | |
| RU2016109940A (ru) | Вакцина против бешенства | |
| CN111527207A (zh) | GalNAc衍生物 | |
| JP2006515277A5 (https=) | ||
| EP1033992A1 (en) | Rnase l activators and antisense oligonucleotides effective to treat rsv infections | |
| RU2007101039A (ru) | Иммуностимулирующие олигонуклеотидные мультимеры | |
| CA2081777A1 (en) | Inhibition of influenza virus replication by oligonucleotides | |
| JP2003531915A (ja) | ヌクレオシドの位置的修飾によるオリゴヌクレオチドＣｐＧ誘導性免疫刺激の調節 | |
| JP2000516200A (ja) | ウシの呼吸病に対するポリヌクレオチドワクチン処方 | |
| KR20100051041A (ko) | 이중-가닥 봉쇄형 핵산 조성물 | |
| JP2019525918A5 (https=) | ||
| JP2025094154A5 (https=) | ||
| CN115252772A (zh) | 人工合成的含CpG单链脱氧寡核苷酸在疫苗中的应用 | |
| JPWO2023022973A5 (https=) | ||
| JPWO2022140587A5 (https=) | ||
| JPWO2023034818A5 (https=) | ||
| JP2024526189A (ja) | 予防および治療のためのｇ－四重鎖含有オリゴヌクレオチド | |
| WO1996023878A1 (en) | Human immunodeficiency virus transcription inhibitors and methods of their use | |
| JP5359883B2 (ja) | 肝炎の治療剤又は予防剤 | |
| CN114127292A (zh) | 减轻反义核酸的毒性的方法 | |
| Barnett et al. | Rotational symmetry in ribonucleotide strand requirements for binding of HIV-1 Tat protein to TAR RNA | |
| WO2024248367A1 (ko) | 단백질 고효율 발현용 mRNA 구조체 플랫폼 |